The Indonesian experience in HPV vaccine procurement highlights the transition from Gavi support to full self-financing within the national immunization program. Facing high cervical cancer incidence, the country initiated phased rollouts since 2016, progressing to nationwide coverage in 2022. Post-Gavi strategies include technology transfer to Biofarma for local vaccine production and cost reduction. Key challenges […]
Country: Indonesia
HPV Vaccination Program in Indonesia: Effectiveness, Scale-Up Costs, Future Prospects, and Policy Recommendations
The poster presents Indonesia’s HPV vaccination program, highlighting its effectiveness, scale-up costs, and policy recommendations. It outlines the use of literature reviews, stakeholder engagement, and benchmarking with other countries to inform technical guidelines, emphasizing optimal scheduling, eligible age groups, and booster evaluation. Cost analyses compare procurement options across vaccine types (bivalent, quadrivalent, nonavalent) and supply […]
Monitoring Temperature Excursions in HPV Vaccine Management in Indonesia: Insights from Internet of Things Digitalization
The study explores Indonesia’s use of IoT-based digital monitoring through the SMILE system to track HPV vaccine storage temperatures. Between July and December 2023, frequent temperature deviations below 2°C and above 8°C were recorded, largely due to increased vaccine volumes from school-based immunization and limited cold chain capacity at Public Health Centers. Data from 21 […]
Post-Introduction Evaluation of HPV Vaccination in Indonesia: a lesson learnt for future program
The study evaluated Indonesia’s HPV vaccination demonstration program through a mixed-methods approach combining desk reviews, field observations, and stakeholder interviews across six districts in three provinces. High coverage among schoolgirls was achieved through integration into existing school health programs and robust cold chain practices. Despite strong acceptance, challenges included inconsistent engagement with religious leaders, inadequate […]
Acceleration of Human Papillomavirus Vaccine Introduction in Indonesia: A Policy Analysis
The policy analysis examines Indonesia’s rapid HPV vaccine scale-up from 20 districts in 2016 to nationwide implementation in 2023, guided by a health policy triangle framework. Key milestones included joint decrees across four ministries, prioritization of domestic vaccine production, and multi-actor engagement with technical support. Policies evolved to strengthen agenda-setting, health systems, and community awareness, […]
Assessment of HPV Vaccination Strategies to Reach Out-of-School Girls Across Indonesia
The study assessed Indonesia’s HPV vaccination strategies for reaching out‑of‑school girls following the 2023 nationwide scale‑up. Despite coverage of in‑school populations, findings revealed no formal strategies, decrees, or coordination mechanisms to reach marginalized groups such as girls in faith‑based schools, urban slums, orphanages, juvenile institutions, or those engaged in child labor. The assessment identified data […]
Indonesia: Multi-sectoral engagement and coordination approaches for HPV vaccine national scale-up
The Ministry of Health of Indonesia detailed its national HPV vaccination scale-up, emphasizing multisectoral collaboration involving education, religious, and home affairs ministries. The program, integrated with school-based immunization, achieved nationwide expansion by 2023, targeting over 2.1 million girls. Key strategies include securing affordable vaccines, enhancing delivery quality, and leveraging digital tools like ASIK and SMILE […]
Country Snapshots – Indonesia
Indonesia introduced the HPV vaccine in phases starting in 2016 and achieved nationwide coverage in 2023, targeting girls aged 11–12 (5th–6th grade). The program uses a two-dose schedule of the quadrivalent vaccine, primarily via school-based delivery with primary health facilities serving out-of-school girls. In 2023, coverage exceeded 90% for both doses. Implementation is supported by […]